Treatment of Acetaminophen Overdose in Pediatric Patients
N-acetylcysteine (NAC) is the definitive treatment for acetaminophen overdose in pediatric patients and should be administered as soon as possible, ideally within 8-10 hours of ingestion, to reduce the risk of hepatotoxicity, liver failure, and mortality. 1
Initial Assessment and Risk Stratification
Obtain a plasma or serum acetaminophen concentration at least 4 hours after ingestion
Use the Rumack-Matthew nomogram to determine risk for hepatotoxicity for acute single ingestions with:
Important: The Rumack-Matthew nomogram should NOT be used for:
- Chronic ingestions or repeated supratherapeutic ingestions
- Unknown time of ingestion
- Presentation >24 hours after ingestion 3
NAC Treatment Protocol
Indications for NAC:
- Acetaminophen levels in "possible risk" or "probable risk" zones on nomogram
- Unknown time of ingestion with concerning acetaminophen level
- Presentation >8 hours after ingestion with concerning history
- Evidence of hepatotoxicity regardless of acetaminophen level
- Repeated supratherapeutic ingestions 1, 4
IV NAC Administration (preferred in pediatric patients):
- Loading dose: 150 mg/kg diluted in appropriate solution over 15-60 minutes
- First maintenance dose: 50 mg/kg over 4 hours
- Second maintenance dose: 100 mg/kg over 16 hours
Total dose: 300 mg/kg over 21 hours 4
Oral NAC Alternative (if IV access unavailable):
- Loading dose: 140 mg/kg
- Maintenance dose: 70 mg/kg every 4 hours for 17 doses 1
Additional Management Considerations
- For patients presenting within 4 hours of ingestion, administer activated charcoal before starting NAC 1
- For massive overdoses (>500 mg/kg), consider adjunctive treatments:
- Fomepizole
- Hemodialysis (in cases with refractory metabolic acidosis or extremely high levels) 5
- Monitor:
- Liver function tests (AST, ALT)
- Coagulation studies (PT/INR)
- Renal function
- Electrolytes and glucose 6
Treatment Duration and Endpoints
- Standard duration: 21 hours for IV protocol
- Consider continuing treatment beyond 21 hours if:
- Treatment may be discontinued when:
- Acetaminophen level is undetectable
- Liver enzymes are normal or improving
- Patient is clinically stable 1
Special Scenarios
Chronic or Repeated Supratherapeutic Ingestion
- Do not use the Rumack-Matthew nomogram
- Evaluate with serum acetaminophen level, liver function tests, and coagulation studies
- Administer NAC if:
- Any detectable acetaminophen level
- Elevated liver enzymes
- Clinical evidence of hepatotoxicity 3
Delayed Presentation (>24 hours)
- Administer NAC regardless of acetaminophen level if there is:
Prognosis and Follow-up
- Early NAC administration (within 8-10 hours) is associated with excellent outcomes and minimal hepatotoxicity 2
- Delayed treatment (>10 hours) increases risk of hepatotoxicity but NAC still beneficial 2
- Most pediatric patients receiving appropriate NAC treatment recover completely without long-term sequelae 4, 7
- Psychiatric evaluation is essential for intentional overdoses, as studies show high rates of psychiatric comorbidities (89% of cases) 7
Pitfalls to Avoid
- Delaying NAC administration while waiting for acetaminophen levels in high-risk scenarios
- Using the Rumack-Matthew nomogram for repeated supratherapeutic ingestions
- Failing to recognize that children under 6 years typically have better outcomes than adolescents, but still require appropriate evaluation and treatment 8
- Underestimating the risk of hepatotoxicity in cases of unintentional repeated supratherapeutic dosing, which can lead to fulminant hepatic failure 6, 3
Early recognition and prompt administration of NAC remain the cornerstones of successful management of acetaminophen overdose in pediatric patients.